{"product_id":"minimally-invasive-fat-reduction-device-market-size-share-trends-analysis-global-2023-2029-medcore-includes-cryolipolysis-device-ultrasound-lipolysis-device","title":"Minimally Invasive Fat Reduction Device Market Size, Share \u0026 Trends Analysis - Global - 2023-2029 - MedCore - Includes: Cryolipolysis Device, Ultrasound Lipolysis Device","description":"\u003cp\u003eMinimally Invasive Fat Reduction Device Market Size, Share \u0026amp; Trends Analysis - Global - 2023-2029 - MedCore - Includes: Cryolipolysis Device, Ultrasound Lipolysis Device\u003c\/p\u003e\n\n\u003cp\u003eThe global market for minimally invasive fat reduction devices was valued at $651.3 million in 2022, with a projected CAGR of 4.7% over the forecast period leading to an estimated value of $897.1 million.\u003c\/p\u003e\n\n\u003cp\u003eThe complete report suite for the global minimally invasive fat reduction device market includes cryolipolysis devices, ultrasound lipolysis devices, laser lipolysis devices, and Kybella® injection segments. Procedure data is further classified into Kybella® injection and non-injectable fat reduction procedures.\u003c\/p\u003e\n\n\u003cp\u003eMARKET DATA INCLUDED\u003c\/p\u003e\n\n\u003cp\u003eUnit Sales, Average Selling Prices, Market Size \u0026amp; Growth Trends\u003cbr\u003e\nProcedure Numbers\u003c\/p\u003e\n\n\u003cp\u003eCOVID-19 Impact Analysis\u003c\/p\u003e\n\n\u003cp\u003eMarket Drivers \u0026amp; Limiters\u003cbr\u003e\nMarket Forecasts Until 2029, and Historical Data to 2019\u003cbr\u003e\nRecent Mergers \u0026amp; Acquisitions\u003cbr\u003e\nCompany Profiles and Product Portfolios\u003cbr\u003e\nLeading Competitors\u003c\/p\u003e\n\n\u003cp\u003eGLOBAL MINIMALLY INVASIVE FAT REDUCTION DEVICE MARKET INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eResearch and development, coupled with the increasing adoption of relevant technologies, have led to the growing popularity of minimally and non-invasive fat reduction methods. The rising awareness of weight management, combined with social media's promotion of the ideal body image, has further fueled the demand for safe and effective fat removal procedures. As a result, the fat reduction procedure volume is expected to continue its growth trajectory, leading to increased sales in the adjustment device market.\u003c\/p\u003e\n\n\u003cp\u003eGLOBAL MINIMALLY INVASIVE FAT REDUCTION DEVICE MARKET SHARE INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eThe global minimally invasive fat reduction device market was dominated by Allergan, Merz Aesthetics, and Cynosure.\u003cbr\u003e\nIn 2022, Allergan, a subsidiary of AbbVie, held the top position in the global minimally invasive fat reduction device market. Allergan's CoolSculpting® machine is the sole cryolipolysis machine with FDA approval, giving the company a substantial market share in this segment. Additionally, Allergan also owns Kybella® (deoxycholic acid), known as Belkyra® in Europe, further cementing its dominance in this market.\u003c\/p\u003e\n\n\u003cp\u003eMARKET SEGMENTATION SUMMARY\u003c\/p\u003e\n\n\u003cp\u003eCryolipolysis Device Market\u003cbr\u003e\nUltrasound Lipolysis Device Market\u003cbr\u003e\nLaser Lipolysis Device Market\u003cbr\u003e\nKybella® Injection Market\u003c\/p\u003e\n\n\u003cp\u003eRESEARCH SCOPE SUMMARY\u003cbr\u003e\nRegions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central \u0026amp; Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)\u003cbr\u003e\nBase Year: 2022\u003cbr\u003e\nForecast Period: 2023-2029\u003cbr\u003e\nHistorical Data: 2019-2022\u003cbr\u003e\nQuantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices\u003cbr\u003e\nQualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis \u0026amp; SWOT for Top Competitors, Mergers \u0026amp; Acquisitions, Company Profiles, Product Portfolios\u003cbr\u003e\nData Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import \u0026amp; Export Data.\u003cbr\u003e\nRead more about iData’s 9-Step Research Methodology\u003c\/p\u003e\n\n\u003cp\u003eWHY CHOOSE IDATA?\u003c\/p\u003e\n\n\u003cp\u003eExperts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.\u003c\/p\u003e\n\n\u003cp\u003eAttention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.\u003c\/p\u003e\n\n\u003cp\u003ePricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ 61 Pages \/ MCW16236173","offer_id":47651444293938,"sku":null,"price":5994.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/minimally-invasive-fat-reduction-device-market-size-share-trends-analysis-global-2023-2029-medcore-includes-cryolipolysis-device-ultrasound-lipolysis-device","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}